Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Vaccine-preventable disease among homeschooled children: two cases of tetanus in Oklahoma.

Johnson MG, Bradley KK, Mendus S, Burnsed L, Clinton R, Tiwari T.

Pediatrics. 2013 Dec;132(6):e1686-9. doi: 10.1542/peds.2013-1636. Epub 2013 Nov 11.

4.

Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.

America Academy of Pediatrics Commitee on Infectious Diseases.

Pediatrics. 2006 Mar;117(3):965-78. Epub 2005 Dec 28.

PMID:
16382131
5.
6.
7.

Middle school vaccination requirements and adolescent vaccination coverage.

Bugenske E, Stokley S, Kennedy A, Dorell C.

Pediatrics. 2012 Jun;129(6):1056-63. doi: 10.1542/peds.2011-2641. Epub 2012 May 7.

PMID:
22566425
8.

Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.

Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glodé MP, Ehresmann KR; Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. kbisgard@cdc.gov.

Pediatrics. 2005 Aug;116(2):e285-94.

PMID:
16061582
11.

How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?

Halperin SA, Sweet L, Baxendale D, Neatby A, Rykers P, Smith B, Zelman M, Maus D, Lavigne P, Decker MD.

Pediatr Infect Dis J. 2006 Mar;25(3):195-200.

PMID:
16511379
12.

Underimmunization among children: effects of vaccine safety concerns on immunization status.

Gust DA, Strine TW, Maurice E, Smith P, Yusuf H, Wilkinson M, Battaglia M, Wright R, Schwartz B.

Pediatrics. 2004 Jul;114(1):e16-22.

PMID:
15231968
13.

Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.

Zepp F, Knuf M, Habermehl P, Mannhardt-Laakmann W, Howe B, Friedland LR.

J Pediatr. 2006 Nov;149(5):603-610.

PMID:
17095328
14.

Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.

Zepp F, Habermehl P, Knuf M, Mannhardt-Laakman W, Howe B, Friedland LR.

Vaccine. 2007 Jul 20;25(29):5248-52. Epub 2007 Jun 4.

PMID:
17583395
15.

Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.

Grimprel E, von Sonnenburg F, Sänger R, Abitbol V, Wolter JM, Schuerman LM.

Vaccine. 2005 May 25;23(28):3657-67.

PMID:
15882526
16.

A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.

Zangwill KM, Eriksen E, Lee M, Lee J, Marcy SM, Friedland LR, Weston W, Howe B, Ward JI.

Pediatrics. 2008 Dec;122(6):e1179-85. doi: 10.1542/peds.2008-1977.

PMID:
19047220
17.

Vaccination coverage among children in kindergarten - United States, 2012-13 school year.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2013 Aug 2;62(30):607-12.

18.

Vaccination coverage among children in kindergarten--United States, 2006-07 school year.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2007 Aug 17;56(32):819-21.

19.

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.

Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A; Stage III Working Group.

Pediatrics. 2001 Nov;108(5):E81.

PMID:
11694665
20.

Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.

Gidengil CA, Sandora TJ, Lee GM.

Expert Rev Vaccines. 2008 Jul;7(5):621-34. doi: 10.1586/14760584.7.5.621. Review.

PMID:
18564017

Supplemental Content

Support Center